I'm becoming a little concerned now
about this letter to the fda by (Biogen?) almost sounds like a strong arm tactic. Big Pharma saying they want approval now because the little guy (Anavex) is ready to win the race. or am I being too simplistic. I see some folks forecasting that the process for Anavex is still developing into 2024,and thats a really long time away ,for traders to play the trading games,and the next game could be setting up for next week. IF BIIB gets a green light from the FDA what will that do to the AVXL share price? I have some concerns that we see the same old butchering of AVXL share price once again. we could see it collapse from 7 back to 3 dollars all over again, if some big door gets slammed shut because a big Pharma gets to receive special treatment in the big money game. Yes, maybe it would mean Anavex does better 3 years from now, but be prepared to see the share price smash down all over again.
Trying to forecast the price patterns is looking complicated once again. We might not see a steady rally climb from here to 10 dollars.As long as the FDA feels pressure from Big Pharma, its still a rigged game in the biotech business. isnt it?
News 
Market Data 
Discover 
